QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.103.056770v1 308/1/228    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Siebert, G. A. Articles by Roberts, M. S. Search for Related Content PubMed PubMed Citation Articles by Siebert, G. A. Articles by Roberts, M. S.

ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Ion-Trapping, Microsomal Binding, and Unbound Drug Distribution in the Hepatic Retention of Basic Drugs

Department of Medicine, University of Queensland, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia

This study investigated the relative contribution of ion-trapping, microsomal binding, and distribution of unbound drug as determinants in the hepatic retention of basic drugs in the isolated perfused rat liver. The ionophore monensin was used to abolish the vesicular proton gradient and thus allow an estimation of ion-trapping by acidic hepatic vesicles of cationic drugs. In vitro microsomal studies were used to independently estimate microsomal binding and metabolism. Hepatic vesicular ion-trapping, intrinsic elimination clearance, permeability-surface area product, and intracellular binding were derived using a physiologically based pharmacokinetic model. Modeling showed that the ion-trapping was significantly lower after monensin treatment for atenolol and propranolol, but not for antipyrine. However, no changes induced by monensin treatment were observed in intrinsic clearance, permeability, or binding for the three model drugs. Monensin did not affect binding or metabolic activity in vitro for the drugs. The observed ion-trapping was similar to theoretical values estimated using the pHs and fractional volumes of the acidic vesicles and the pK_a values of drugs. Lipophilicity and pK_a determined hepatic drug retention: a drug with low pK_a and low lipophilicity (e.g., antipyrine) distributes as unbound drug, a drug with high pK_a and low lipophilicity (e.g., atenolol) by ion-trapping, and a drug with a high pK_a and high lipophilicity (e.g., propranolol) is retained by ion-trapping and intracellular binding. In conclusion, monensin inhibits the ion-trapping of high pK_a basic drugs, leading to a reduction in hepatic retention but with no effect on hepatic drug extraction.

Address correspondence to: Professor Michael S. Roberts, Department of Medicine, University of Queensland, Princess Alexandra Hospital, Woolloongabba Qld 4102, Australia. E-mail: mroberts{at}soms.uq.edu.au

This article has been cited by other articles:

				T. Hay, R. Jones, K. Beaumont, and M. Kemp Modulation of the Partition Coefficient between Octanol and Buffer at pH 7.4 and pKa to Achieve the Optimum Balance of Blood Clearance and Volume of Distribution for a Series of Tetrahydropyran Histamine Type 3 Receptor Antagonists Drug Metab. Dispos., September 1, 2009; 37(9): 1864 - 1870. [Abstract] [Full Text] [PDF]

				S. Park, G. E. P. Ropella, S. H. J. Kim, M. S. Roberts, and C. A. Hunt Computational Strategies Unravel and Trace How Liver Disease Changes Hepatic Drug Disposition J. Pharmacol. Exp. Ther., January 1, 2009; 328(1): 294 - 305. [Abstract] [Full Text] [PDF]

				D. W. Angus, J. A. Baker, R. Mason, and I. J. Martin The Potential Influence of CO2, as an Agent for Euthanasia, on the Pharmacokinetics of Basic Compounds in Rodents Drug Metab. Dispos., February 1, 2008; 36(2): 375 - 379. [Abstract] [Full Text] [PDF]

				D. Hallifax and J. B. Houston Saturable Uptake of Lipophilic Amine Drugs into Isolated Hepatocytes: Mechanisms and Consequences for Quantitative Clearance Prediction Drug Metab. Dispos., August 1, 2007; 35(8): 1325 - 1332. [Abstract] [Full Text] [PDF]

				E. Salvatorelli, S. Guarnieri, P. Menna, G. Liberi, A. M. Calafiore, M. A. Mariggio, A. Mordente, L. Gianni, and G. Minotti Defective One- or Two-electron Reduction of the Anticancer Anthracycline Epirubicin in Human Heart: RELATIVE IMPORTANCE OF VESICULAR SEQUESTRATION AND IMPAIRED EFFICIENCY OF ELECTRON ADDITION J. Biol. Chem., April 21, 2006; 281(16): 10990 - 11001. [Abstract] [Full Text] [PDF]

				D. Y. Hung, G. A. Siebert, P. Chang, M. W. Whitehouse, L. Fletcher, D. H. G. Crawford, and M. S. Roberts Hepatic pharmacokinetics of propranolol in rats with adjuvant-induced systemic inflammation Am J Physiol Gastrointest Liver Physiol, February 1, 2006; 290(2): G343 - G351. [Abstract] [Full Text] [PDF]

				G. Morissette, E. Moreau, R. C.-Gaudreault, and F. Marceau N-Substituted 4-Aminobenzamides (Procainamide Analogs): An Assessment of Multiple Cellular Effects Concerning Ion Trapping Mol. Pharmacol., December 1, 2005; 68(6): 1576 - 1589. [Abstract] [Full Text] [PDF]

				D. Y. Hung, G. A. Siebert, P. Chang, Y. G. Anissimov, and M. S. Roberts Disposition Kinetics of Propranolol Isomers in the Perfused Rat Liver J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 822 - 829. [Abstract] [Full Text] [PDF]

				G. Morissette, E. Moreau, R. C.-Gaudreault, and F. Marceau Massive Cell Vacuolization Induced by Organic Amines Such as Procainamide J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 395 - 406. [Abstract] [Full Text] [PDF]